Mark Rimer
Directeur/Membre du Conseil chez Kuzari Group LLC
Profil
Mark Rimer is currently a Director & Partner at Kuzari Group LLC since 2009.
He was previously a Director at Transgenomic, Inc. and Precipio Diagnostics LLC.
He also served as an Independent Director at Precipio, Inc. from 2012 to 2021.
Mr. Rimer completed his undergraduate degree at the University of Bristol and earned an MBA from The Leonard N Stern School of Business.
Postes actifs de Mark Rimer
| Sociétés | Poste | Début |
|---|---|---|
Kuzari Group LLC
 Kuzari Group LLC Financial ConglomeratesFinance Kuzari Group LLC operates as a private investment and strategic development firm. It focuses on investing in and developing small businesses which represents long-term value creation opportunities. The company was founded by Benjamin Gerut in 2009 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/09/2009 |
Anciens postes connus de Mark Rimer
| Sociétés | Poste | Fin |
|---|---|---|
| PRECIPIO, INC. | Directeur/Membre du Conseil | 01/03/2021 |
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Directeur/Membre du Conseil | - |
Precipio Diagnostics LLC
 Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Precipio Diagnostics LLC operates as a cancer diagnostics reference laboratory. It offers its customers community oncologists and hospitals access to academic institutions and has combined academic-level excellence with the sales and marketing expertise, the proper operational processes and the necessary service level standards required to deliver proper support. The company was founded by Ilan Danieli in 2011 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | - |
Formation de Mark Rimer
| University of Bristol | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRECIPIO, INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
Kuzari Group LLC
Kuzari Group LLC Financial ConglomeratesFinance Kuzari Group LLC operates as a private investment and strategic development firm. It focuses on investing in and developing small businesses which represents long-term value creation opportunities. The company was founded by Benjamin Gerut in 2009 and is headquartered in New York, NY. | Finance |
Precipio Diagnostics LLC
Precipio Diagnostics LLC Medical/Nursing ServicesHealth Services Precipio Diagnostics LLC operates as a cancer diagnostics reference laboratory. It offers its customers community oncologists and hospitals access to academic institutions and has combined academic-level excellence with the sales and marketing expertise, the proper operational processes and the necessary service level standards required to deliver proper support. The company was founded by Ilan Danieli in 2011 and is headquartered in New Haven, CT. | Health Services |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
